Next Article in Journal
Making Sense out of Antisense Transcription in Human T-Cell Lymphotropic Viruses (HTLVs)
Next Article in Special Issue
Foamy Virus Biology and Its Application for Vector Development
Previous Article in Journal
Caging the Beast: TRIM5α Binding to the HIV-1 Core
Previous Article in Special Issue
The Inside Out of Lentiviral Vectors
Article Menu

Article Versions

Export Article

Open AccessReview
Viruses 2011, 3(5), 429-455; doi:10.3390/v3050429

Retroviral Vectors: Post Entry Events and Genomic Alterations

1
Department of Translational Oncology, German Cancer Research Center, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany
2
National Center for Tumor Diseases, Im Neuenheimer Feld 581, 69120 Heidelberg, Germany
*
Authors to whom correspondence should be addressed.
Received: 9 February 2011 / Revised: 24 March 2011 / Accepted: 5 April 2011 / Published: 29 April 2011
(This article belongs to the Special Issue Retroviral Vectors)
Download PDF [687 KB, uploaded 12 May 2015]

Abstract

The curative potential of retroviral vectors for somatic gene therapy has been demonstrated impressively in several clinical trials leading to sustained long-term correction of the underlying genetic defect. Preclinical studies and clinical monitoring of gene modified hematopoietic stem and progenitor cells in patients have shown that biologically relevant vector induced side effects, ranging from in vitro immortalization to clonal dominance and oncogenesis in vivo, accompany therapeutic efficiency of integrating retroviral gene transfer systems. Most importantly, it has been demonstrated that the genotoxic potential is not identical among all retroviral vector systems designed for clinical application. Large scale viral integration site determination has uncovered significant differences in the target site selection of retrovirus subfamilies influencing the propensity for inducing genetic alterations in the host genome. In this review we will summarize recent insights gained on the mechanisms of insertional mutagenesis based on intrinsic target site selection of different retrovirus families. We will also discuss examples of side effects occurring in ongoing human gene therapy trials and future prospectives in the field.
Keywords: retroviral vectors; retroviral integration; gene therapy; insertional mutagenesis; vector genotoxicity; Leukemia; common insertion sites retroviral vectors; retroviral integration; gene therapy; insertional mutagenesis; vector genotoxicity; Leukemia; common insertion sites
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Nowrouzi, A.; Glimm, H.; Von Kalle, C.; Schmidt, M. Retroviral Vectors: Post Entry Events and Genomic Alterations. Viruses 2011, 3, 429-455.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top